Skip to main content
Log in

Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients?

  • Short Communication
  • Protein Binding, Flavone Acetic Acid, Pharmacology
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

We investigated the differences in plasma protein binding of flavone acetic acid (FAA) in mice and men in an attempt to explain the inter-species differences in response. In vitro data indicate both qualitative and quantitative differences in FAA protein binding: approximately 80% is bound in humans, with two different types of binding site identified; in mice, 70% is bound and only one binding site could be described. Protein binding is dose-dependent in both species. Plasma samples from 20 patients receiving FAA showed that most achieved levels that would be active in mice. We conclude that these differences in protein binding are insufficient to explain totally the observed differences in response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Belforte G, Bona B, Milanese M (1984) Advanced modeling and identification techniques for metabolic processes. CRC Crit Rev Biomed Eng 10(4): 275

    Google Scholar 

  2. Bibby MC, Double JA, Phillips RM, Loadman PM (1987) Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid). Br J Cancer 55: 159

    Google Scholar 

  3. Corbett TH, Bissery MC, Wozniak A, Plowman J, Polin L, Tapazoglou E, Dieckman J, Valeriote F (1986) Activity of flavone acetic acid (NSC-347512) against solid tumours of mice. Invest New Drugs 4: 207

    Google Scholar 

  4. Kerr DJ, Kaye SB, Cassidy J, Bradley C, Rankin EM, Adams L, Setanoians A, Young T, Forrest G, Soukop M, Clavel M (1987) A phase I and pharmacokinetic study of flavone acetic acid. Cancer Res 47: 6776

    Google Scholar 

  5. Plowman J, Narayanan V, Dykes D, Szarvasi E, Briet P, Yoder OC, Paull K (1986) Flavone acetic acid (NSC-347512), a novel agent with preclinical antitumour activity against colon adenocarcinoma 38 in mice. Cancer Treat Rep 70: 631

    Google Scholar 

  6. Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51: 660

    Google Scholar 

  7. Zaharko DS, McCormack JJ (1987) A binding isotherm useful for predicting free drug in-vivo. Pharmacologist 29(3): 74

    Google Scholar 

  8. Zaharko DS, Grieshaber CK, Plowman J, Craddock JC (1986) Therapeutic and pharmacokinetic relationships of flavone acetic acid: an agent with activity against solid tumours. Cancer Treat Rep 70(12): 1415

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cassidy, J., Kerr, D.J., Setanoians, A. et al. Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients?. Cancer Chemother. Pharmacol. 23, 397–400 (1989). https://doi.org/10.1007/BF00435845

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00435845

Keywords

Navigation